CN Patent

CN109776544B — 吡唑并[3,4-d]嘧啶类化合物及其制备方法和用途

Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2022-02-01 · 4y expired

What this patent protects

在本发明涉及的化合物为一种布鲁顿酪氨酸激酶的抑制剂。此外，本发明阐述了包含该化合物的药物组分及制剂，及这类激酶抑制剂的用途，可单一用药或与其它化合物联合用药，用来治疗由激酶介导或激酶依赖的症状。

USPTO Abstract

在本发明涉及的化合物为一种布鲁顿酪氨酸激酶的抑制剂。此外，本发明阐述了包含该化合物的药物组分及制剂，及这类激酶抑制剂的用途，可单一用药或与其它化合物联合用药，用来治疗由激酶介导或激酶依赖的症状。

Drugs covered by this patent

Patent Metadata

Patent number
CN109776544B
Jurisdiction
CN
Classification
—
Expires
2022-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Institute of Pharmaceutical Industry
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.